-
CTOP for μ-Opioid Receptor Research
2026-09-15
CTOP provides a selective pharmacological checkpoint for separating μ-opioid receptor-dependent effects from downstream circuit activity in binding, signaling, and pain assays. This workflow-oriented guide shows how to prepare, apply, and troubleshoot CTOP when investigating mechanical hypersensitivity, opioid tolerance, and brain-to-spinal pain mechanisms.
-
Indazole/Indole Glucagon Receptor Antagonists
2026-09-14
The reference study describes a medicinal chemistry series that replaces the pyrazole-centered architecture of MK-0893 with indazole, indole, and related azaindole scaffolds. Structure–activity relationship studies produced potent glucagon receptor antagonists, including GRA 16d, which reduced glucagon-driven glucose excursions in humanized-receptor mouse models after oral dosing.
-
Radicicol for Mitochondrial Senescence Assays
2026-09-14
Radicicol, a potent Hsp90 inhibitor and ATPase/kinase probe, can sharpen interpretation of mitochondrial stress and inflammatory senescence experiments. This article connects its biochemical profile with the α-KG–LKB1–AMPK findings in periodontal stem cells while defining practical controls and experimental limits.
-
PEDV Hijacks IMPDH-Dependent Nucleotide Synthesis
2026-09-13
A recent study identifies IMPDH2-dependent guanine nucleotide biosynthesis as a host metabolic requirement for porcine epidemic diarrhea virus replication. By combining untargeted metabolomics with genetic knockdown and merimepodib inhibition, the work supports IMPDH as a host-directed antiviral target while revealing cell-type-specific metabolic responses to PEDV infection.
-
PP 1: Src Family Tyrosine Kinase Inhibitor Guide
2026-09-12
PP 1 enables controlled interrogation of Lck, Fyn, Lyn, and related Src-family signaling in cancer and immune-cell assays. This practical guide connects dose design, phospho-readouts, RET transformation models, T-cell activation modulation, and mechanism-focused troubleshooting.
-
Psora 4: Practical Kv1.3 Blocker Workflows
2026-09-11
Psora 4 is a selective Kv1.3 blocker for connecting membrane-potential control with T cell calcium signaling, effector-memory biology, and inflammatory disease models. This workflow-focused guide covers dosing, assay controls, KCNE4-aware interpretation, and troubleshooting from cell assays to anti-GBM GN research.
-
D-N-Acetylgalactosamine: Protocol Guide
2026-09-11
D-N-Acetylgalactosamine (SKU B7904) provides a defined amino sugar reagent for glycoprotein constituent measurements, brain heteropolysaccharides analysis, and controlled glycosylation pathway workflows. Its water and DMSO solubility support aqueous assay preparation, while ethanol insolubility and the lack of long-term solution-storage guidance require deliberate solvent selection and fresh preparation.
-
EZ Cap™ Mouse IL-12 mRNA: Assay Design Guide
2026-09-10
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) provides a defined cytokine payload for studying immune activation, translation, and extrahepatic delivery. This assay-focused guide explains how to separate transcript performance from delivery-platform effects using evidence from an enveloped virus-mimicking particle study.
-
2'-O-Methyladenosine: From Sample to Signal
2026-09-10
Explore how 2'-O-Methyladenosine can be evaluated as an RNA modification nucleoside, metabolic probe, and nucleoside analog research tool. This article translates recent UHPLC–MS/MS advances into practical decisions about identity, extraction, matrix effects, and cell-based assay interpretation.
-
Novobiocin BA1116: Reliable Cell Assay Workflows
2026-09-09
Learn how Novobiocin (SKU BA1116) can improve the design and interpretation of viability, proliferation, cytotoxicity, antiparasitic, and antiviral assays. This scenario-based guide links mechanism, dose selection, solvent compatibility, data validation, and practical vendor evaluation to published evidence.
-
N1-Methylpseudouridine in Translational CRISPRa
2026-09-09
N1-Methylpseudouridine can turn mRNA delivery from a background variable into a controllable design parameter. This thought-leadership analysis connects modified nucleoside chemistry with CRISPRa-based splice-variant research, while separating established evidence from testable translational opportunity.
-
Tofacitinib citrate: JAK-STAT Research Workflows
2026-09-08
Build reproducible immune-cell and endothelial inflammation assays with Tofacitinib citrate, using concentration-response design rather than a single endpoint. The workflow connects JAK3-focused pharmacology with cytokine, adhesion, coagulation, apoptosis, and T-cell differentiation readouts.
-
N1-Methylpseudouridine in CRISPRa RNA Assays
2026-09-08
Explore how N1-Methylpseudouridine can support mRNA translation enhancement in CRISPRa-based RNA assays without confusing delivery performance with splice biology. This article connects modified nucleoside selection to assay design, controls, and evidence-based interpretation.
-
ML-7 Hydrochloride: MLCK Inhibition in Cardiac Research
2026-09-07
ML-7 hydrochloride is a selective myosin light chain kinase inhibitor used to interrogate MLC phosphorylation in cardiac and vascular models. Its reported 300 nM Ki, pathway-focused mechanism, and compatibility with ischemia/reperfusion injury research make it useful for mechanistic studies, but product-dossier findings should not be treated as clinical evidence.
-
N1-Methylpseudo-UTP: Chemistry to Translation
2026-09-07
N1-Methyl-Pseudouridine-5'-Triphosphate is more than a specialized nucleotide replacement. Its value lies in connecting RNA chemistry, ribosome behavior, transcript quality, and translational development. This thought-leadership guide interprets evidence on decoding fidelity and reverse transcription while providing practical guidance for in vitro transcription, RNA stability enhancement, mRNA vaccine development, and broader RNA therapeutic workflows.